| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50242-103-01 | 50242-103 | HUMAN PRESCRIPTION DRUG | POLIVY | polatuzumab vedotin | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | INTRAVENOUS | 20200918 | N/A | BLA | BLA761121 | Genentech, Inc. | POLATUZUMAB VEDOTIN | 30 mg/1.88mL | 1 VIAL in 1 CARTON (50242-103-01) / 6 mL in 1 VIAL |
| 50242-105-01 | 50242-105 | HUMAN PRESCRIPTION DRUG | POLIVY | polatuzumab vedotin | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | INTRAVENOUS | 20190610 | N/A | BLA | BLA761121 | Genentech, Inc. | POLATUZUMAB VEDOTIN | 140 mg/7.52mL | 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-105-01) / 20 mL in 1 VIAL, SINGLE-DOSE |